An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells.
暂无分享,去创建一个
[1] Jean-Louis Mergny,et al. A New Steroid Derivative Stabilizes G-Quadruplexes and Induces Telomere Uncapping in Human Tumor Cells , 2007, Molecular Pharmacology.
[2] Stephen Neidle,et al. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. , 2006, Journal of medicinal chemistry.
[3] Stephen Neidle,et al. Mechanism of acridine-based telomerase inhibition and telomere shortening. , 2007, Biochemical pharmacology.
[4] Jean-Louis Mergny,et al. Targeting telomeres and telomerase. , 2008, Biochimie.
[5] Jean-Louis Mergny,et al. Affinity and selectivity of G4 ligands measured by FRET. , 2005, Nucleic acids symposium series.
[6] Hamid Morjani,et al. Telomestatin-induced Telomere Uncapping Is Modulated by POT1 through G-overhang Extension in HT1080 Human Tumor Cells* , 2006, Journal of Biological Chemistry.
[7] Barbara Benassi,et al. Biological Activity of the G-Quadruplex Ligand RHPS4 (3,11-Difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) Is Associated with Telomere Capping Alteration , 2004, Molecular Pharmacology.
[8] M. Teulade‐Fichou,et al. A hitchhiker's guide to G-quadruplex ligands. , 2008, Organic & biomolecular chemistry.
[9] Julie E Reed,et al. TRAP-LIG, a modified telomere repeat amplification protocol assay to quantitate telomerase inhibition by small molecules. , 2008, Analytical biochemistry.
[10] Stephen Neidle,et al. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. , 2005, Cancer research.
[11] Jia-Heng Tan,et al. Design of selective G-quadruplex ligands as potential anticancer agents. , 2008, Mini reviews in medicinal chemistry.
[12] T. Bryan,et al. Physiological relevance of telomeric G‐quadruplex formation: a potential drug target , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.
[13] K. Shin‐ya,et al. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. , 2006, Cancer research.
[14] C. Autexier,et al. The structure and function of telomerase reverse transcriptase. , 2006, Annual review of biochemistry.
[15] S. Neidle,et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. , 1997, Journal of medicinal chemistry.
[16] T. Lange,et al. Shelterin: the protein complex that shapes and safeguards human telomeres , 2005 .
[17] E. Gilson,et al. G-Quadruplex Ligand RHPS4 Potentiates the Antitumor Activity of Camptothecins in Preclinical Models of Solid Tumors , 2008, Clinical Cancer Research.
[18] B. Guyen,et al. Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors. , 2004, Bioorganic & medicinal chemistry letters.
[19] J. Mergny,et al. Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[21] W. Hahn,et al. Inhibition of telomerase limits the growth of human cancer cells , 1999, Nature Medicine.